Cognitive Research Corporation

Endpoint strategy can shape the trajectory of your program. At CRC, we leverage our extensive experience with sensitive neuroscience endpoints to maximize your asset's potential for success. Our experts collaborate seamlessly across functions to ensure every scale and biomarker aligns with your program objectives, every subject enrolled meets the defined criteria, and every data point is collected and monitored with precision. ? Our meticulous approach has led to 81% positive Phase II and 93% positive Phase III results in the trials we support. With CRC, you can trust that if your therapy is effective, you'll have the robust data necessary to prove it. ? #BoldResearch #ClinicalTrials #Endpoints #ABetterCROExperience

Is your CRO partner truly invested in your success, or just managing the process? At CRC, we take a proactive approach to every study, working as an extension of your team to anticipate challenges, secure endpoints, and deliver high-quality data when you need it. See how our collaborative strategies led to an FDA approval in a recent program: https://lnkd.in/exHV8U2Z Want to partner with a team fully committed to advancing your #BoldResearch? Contact us to connect with Dr. Tom Hochadel at #SIRS2025 or schedule a call with our #CNS experts. #ABetterCROExperience #Neuroscience #Schizophrenia #ClinicalResearch

This Friday, Dr. Djouher Hough will engage in critical discussions and explore the latest in psychedelic research at #ISRP2025. Having recently led over 10 psychedelic clinical trials as a principal investigator, Dr. Hough brings invaluable expertise in navigating DEA and FDA regulatory environments, optimizing trial design for #psychedelic assets, and advancing innovative therapeutics for mental health. ? Interested in the latest findings or looking to collaborate on future projects? Schedule a conversation with our experts: https://lnkd.in/ePsx8FmE ? #BoldResearch #ABetterCROExperience #PsychedelicResearch

Last week at #ISCTM25, CRC’s Dr. Gary Kay and Brandy Isaacks were deeply engaged in pivotal discussions and working group meetings, exploring the latest advancements in #CNS trial methodology and opportunities to enhance the efficiency and efficacy of clinical research. At CRC, our steadfast commitment to scientific rigor ensures that we provide our sponsors with the expertise and insights needed to successfully navigate their clinical pathways. #ABetterCROExperience #BoldResearch #ScientificRigor

Attending #SIRS25 next month? Connect with Dr. Tom Hochadel to discuss the latest in schizophrenia research and strategies to move clinical trials forward with speed and precision. With experience supporting two recent FDA approvals to advance #schizophrenia care, our team understands what it takes to navigate complexity, execute with urgency, and deliver actionable results. Contact us to schedule a conversation: https://lnkd.in/dSnvMMVm #BoldResearch #ABetterCROExperience #CIAS #Agitation

Fresh from #SCOPE2025, Tiffany Smith, MS is a key player in enhancing the efficiency and effectiveness of the clinical trials we support. As Director of Vendor Procurement and Management, she fosters solution-driven collaborations that bring real value to our sponsors. At CRC, vendor relationships are more than just contracts. They are strategic partnerships that drive seamless execution and smarter operations. With Tiffany’s expertise, we are continually optimizing how we deliver #ABetterCROExperience. #BoldResearch #VendorManagement #ClinicalTrials

#ISCTM25 is almost here, and the CRC team is ready to connect! Advancing #BoldResearch requires urgency, consistency, and the right expertise. From seamless trial execution to delivering high-quality data to support your next steps, we partner with sponsors to overcome obstacles and reach milestones. If you’re attending, we’d welcome the opportunity to meet and discuss what’s next for your program. Schedule a meeting to connect: https://lnkd.in/dSnvMMVm #ABetterCROExperience #ClinicalTrials #CNS

As we launch into 2025, CRC is energized by our commitment to providing a better CRO experience. Our annual kick-off meeting reinforced what drives us every day: helping sponsors move their #BoldResearch forward with clarity, urgency, and a team that is fully aligned on what it takes to deliver. At CRC, we do more than support your studies. We take ownership in advancing your programs with the expertise and execution needed to meet your milestones. ? #ABetterCROExperience #ClinicalResearch

Attending #ISCTM25 next month? Meet with Dr. Gary Kay and Brandy Isaacks to discuss your #CNS program objectives and tailored solutions to help you reach them. From meeting critical milestones with urgency to delivering quality data that supports your next steps, our team is committed to driving #BoldResearch forward. Schedule a conversation to explore what’s possible: https://lnkd.in/dSnvMMVm #ABetterCROExperience #ClinicalTrials

Facing tight timelines? #ChallengeAccepted. At CRC, we ensure that the right personnel, sites, vendors, and designs are in place from day one to avoid delays and keep your program on track. ? Explore our urgency in action through a recent vignette highlighting how our team helped a biotech meet the First Patient In milestone in just 6 weeks: https://lnkd.in/dzg_u2Yi ? #BoldResearch #ABetterCROExperience #ClinicalResearch